TY - JOUR
T1 - Cervical preparation using laminaria with adjunctive buccal misoprostol before second-trimester dilation and evacuation procedures
T2 - A randomized clinical trial
AU - Edelman, Alison B.
AU - Buckmaster, John G.
AU - Goetsch, Martha
AU - Nichols, Mark D.
AU - Jensen, Jeffrey T.
N1 - Copyright:
Copyright 2010 Elsevier B.V., All rights reserved.
PY - 2006/2
Y1 - 2006/2
N2 - Objective: This study was undertaken to determine whether buccal misoprostol improves cervical preparation achieved with laminaria before second-trimester dilation and evacuation procedures. Study design: A randomized, double blind, placebo-controlled trial of preoperative cervical preparation with overnight laminaria and either buccal placebo or 400 μg buccal misoprostol approximately 90 minutes before second-trimester surgical abortion. Block randomization was used to provide balanced enrollment into 2 separate gestational age study groups: early (13-156/7) and mid (16-20 6/7) second trimester. Surgeons tested maximal cervical dilation by inserting the largest dilator that could be passed through the cervical os without force. Subject demographics and preprocedure symptoms were tracked. Results: Groups were similar in regard to age, gravity, parity, delivery type, and gestational age. Data were analyzed from 125 women in the 13 to 15 6/7 (30 misoprostol, 32 placebo) and 16 to 206/7 (31 misoprostol, 32 placebo) gestational age groups. Overall, misoprostol treatment did not improve the initial mean dilation achieved with laminaria alone in either the 13 to 156/7 (46.0 fr ± 5.0; placebo 45.0 fr ± 6.2, P = .68) or 16 to 206/7 (50.9 fr ± 5.6, placebo 48.9 fr ± 5.2, P = .16) groups. However, a subanalysis of gestations 19 weeks or more demonstrated significantly greater dilation in the misoprostol group (53.6 fr fr ± 5.3, placebo 48.5 fr ± 5.0, P = .01). Subjects receiving misoprostol reported significantly more cramping than those receiving placebo (13-156/7 weeks misoprostol 25/30, 83%; placebo 17/32, 53%, P = .02; 16-206/7 week misoprostol 25/31, 81%, placebo 16/32, 50%, P = .02). Conclusion: Cervical dilation with laminaria is augmented by 400 μg buccal misoprostol in gestations 19 weeks or more, but not in earlier gestations. Misoprostol causes more abdominal cramping.
AB - Objective: This study was undertaken to determine whether buccal misoprostol improves cervical preparation achieved with laminaria before second-trimester dilation and evacuation procedures. Study design: A randomized, double blind, placebo-controlled trial of preoperative cervical preparation with overnight laminaria and either buccal placebo or 400 μg buccal misoprostol approximately 90 minutes before second-trimester surgical abortion. Block randomization was used to provide balanced enrollment into 2 separate gestational age study groups: early (13-156/7) and mid (16-20 6/7) second trimester. Surgeons tested maximal cervical dilation by inserting the largest dilator that could be passed through the cervical os without force. Subject demographics and preprocedure symptoms were tracked. Results: Groups were similar in regard to age, gravity, parity, delivery type, and gestational age. Data were analyzed from 125 women in the 13 to 15 6/7 (30 misoprostol, 32 placebo) and 16 to 206/7 (31 misoprostol, 32 placebo) gestational age groups. Overall, misoprostol treatment did not improve the initial mean dilation achieved with laminaria alone in either the 13 to 156/7 (46.0 fr ± 5.0; placebo 45.0 fr ± 6.2, P = .68) or 16 to 206/7 (50.9 fr ± 5.6, placebo 48.9 fr ± 5.2, P = .16) groups. However, a subanalysis of gestations 19 weeks or more demonstrated significantly greater dilation in the misoprostol group (53.6 fr fr ± 5.3, placebo 48.5 fr ± 5.0, P = .01). Subjects receiving misoprostol reported significantly more cramping than those receiving placebo (13-156/7 weeks misoprostol 25/30, 83%; placebo 17/32, 53%, P = .02; 16-206/7 week misoprostol 25/31, 81%, placebo 16/32, 50%, P = .02). Conclusion: Cervical dilation with laminaria is augmented by 400 μg buccal misoprostol in gestations 19 weeks or more, but not in earlier gestations. Misoprostol causes more abdominal cramping.
KW - Dilation and evacuation
KW - Laminaria
KW - Misoprostol
KW - Second-trimester abortion
UR - http://www.scopus.com/inward/record.url?scp=31844432809&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=31844432809&partnerID=8YFLogxK
U2 - 10.1016/j.ajog.2005.08.016
DO - 10.1016/j.ajog.2005.08.016
M3 - Article
C2 - 16458640
AN - SCOPUS:31844432809
SN - 0002-9378
VL - 194
SP - 425
EP - 430
JO - American Journal of Obstetrics and Gynecology
JF - American Journal of Obstetrics and Gynecology
IS - 2
ER -